Ensign Group runs nursing homes and rehab centers across 13 states, offering post-acute care, therapy, and senior living—think of it as a chain of recovery hotels for elderly patients.
Revenue comes from Skilled Services (nursing and therapy) and Real Estate leasing, with annual revenue of USD 5.06B and net margin around 6.8%—a low-margin, high-volume business with recurring government and insurance payments.
Local licenses and real estate create barriers, but large chains like Genesis Healthcare and Sabra Health Care REIT compete aggressively, and Medicare reimbursement cuts are eroding pricing power.
Key events, in time order
Rosen Law Firm reiterates investigation based on Hunterbrook short-seller report, urging affected investors to contact, event continues.
Rosen and Kaplan Fox each issued separate notices, confirming the investigation's expansion
SA cites acquisition-driven growth but rising cash burn and regulatory risks
Q2 GAAP EPS $1.68, adj EPS $1.92; FY adj EPS guidance raised to $7.75-7.85, revenue to $5.87-5.92B
MW estimates ~20% of ENSG's SNFs rent administrator licenses to deceive CMS & states; compliance alone cuts 2027 EBIT ~35% vs consensus, slows growth from ~11% to ~2%, with FCA exposure
None yet
None yet
The Ensign Group is analyzed for its long-term dividend-adjusted CAGRs within a healthcare portfolio, indicating a focus on fundamental performance and dividend inclusion.
Main discussion
No comments yet.
Facts and opinions separated · All items sourced · Not investment advice
